Skip to content

Contact +44 (0) 20 7060 7474 email us

Supplements

Nutraceuticals Market - India

 

Publication Date September 2009
Publisher Netscribes (India)
Product Type Report
Pages 30
ISBN Number not applicable
Product Code NSB00003

Price

£195.00
approximately: $295 | €218

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Total market for Nutraceuticals in India is valued at INR 44 bn in 2009; it is estimated to reach INR 95 bn in 2013. Market comprises of two segments - Food Supplements and Vitamins & Minerals.

The report provides a snapshot of the market including its segments food supplements, and vitamins and minerals. An overview gives a quick picture of the market with estimated market size, growth rate and key products and examples. An analysis of drivers reveals that increasing shift towards preventive therapies, increase in disposable income, increase in healthcare spending, ageing population, pharma retail growth, and favourable pricing environment is driving growth in this sector. The key challenges identified include lack of standardization, high pricing, lack of awareness, marketing and distribution challenge. Future trends identified include fortified foods, ayurvedic Nutraceuticals and foreign tie-ups. The competitive landscape identifies major players in this sector. The report also provides details of the key developments and private equity investments in this sector.

Contents

  • Page 1: Executive Summary
  • Introduction
    • Page 2: Classification of Nutraceuticals
  • Market Overview
    • Page 3: Market Overview, Market Size, Growth and Market Segments
    • Page 4: Market - Overview: Food Supplement & Vitamins and Minerals Market
  • Drivers & Challenges
    • Page 5: Summary
    • Page 6- 9: Drivers
    • Page: 10- 12: Challenges
  • Trends
    • Page 13: Summary
    • Page 14-15: Trends
  • Government Regulations
    • Page 16: Food Safety and Standards Act 2006
  • Competition
    • Page 17: Competition Overview
    • Page 18-28: Major Players
  • PE Investments
    • Page 29: PE Investments
  • Key Developments
    • Page 30: Key Developments